Integer Holdings Corp (ITGR)

Integer’s revenue is organised around three product areas: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation, and Other Markets. In cardio and vascular applications, the company produces technologies used in products such as catheters, guidewires, delivery systems, and related interventional devices. In cardiac rhythm management and neuromodulation, it supplies components and technologies for implantable and wearable systems, including power solutions and device assemblies. Its other markets activities include selected non-medical and specialised applications where the company’s precision manufacturing and battery expertise can be applied.

The business operates as a single reporting segment, reflecting the common capabilities it uses across product lines: design support, advanced manufacturing, supply chain management, and regulatory-compliant production. Integer generates a large share of its revenue in the United States, while also maintaining a manufacturing and operating presence in locations such as Ireland, Puerto Rico, Costa Rica, and other international markets.

Integer’s role in the medical device supply chain is distinctive because it often acts as a long-term development and production partner rather than a simple parts supplier. Its customers depend on the company for technical know-how, scale manufacturing, and consistent quality in products that are closely tied to patient outcomes.